COPENHAGEN, Denmark— Recent evidence supports repeated corneal cross-linking as an effective and safe option for patients with progressive ectasia following primary CXL failure.Results from a study evaluating repeated CXL (re-CXL) conducted at the ELZA…
Is Tirzepatide Easier on the Eyes Than GLP-1s?
Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients with type 2 diabetes than using GLP-1 receptor agonists, a study finds. Medscape Medical News
Infant Hydrocortisone Shows No Developmental Harm Later
Neonatal hydrocortisone vs placebo for premature infants at risk for bronchopulmonary dysplasia shows no benefit or harm and no difference in functional impairment by the time they reach kindergarten. Medscape Medical News
Lecture highlights breakthrough advances in AMD brought by AI
PARIS — AI is advancing our understanding of the complexities of age-related macular degeneration, according to a presenter.At the Euretina congress Ursula Schmidt-Erfurth, MD, said AI and AI-based tools are providing guidance on disease management, su…
Q&A: Medicare PFS will benefit primary care, but budget neutrality is ‘the bigger issue’
Several changes in the 2026 Medicare Physicians Fee Schedule, or PFS, will help to better support primary, preventive and comprehensive health care, according to several organizations.For example, the PFS introduces an efficiency adjustment that ACP sa…
IRX-101 shows promise in ocular surface sterilization
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Jennifer I. Lim, MD, MBA, highlights a study on IRX-101, which may lead to better ocular surface sterilization with less discomfort for patients.IRX-101 (iRenix Medical), or ch…